A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Varian, a Siemens Healthineers Company
Study ID
NCT07824583
Status
Recruiting

Conditions

  • Abdominal Cancer
  • Liver Cancer, Adult
  • Lung Cancer (Diagnosis)
  • Pancreatic Cancer
  • Thoracic Cancers

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Next Generation Delivery System (NGDS) — DEVICE
    Participant will receive a "mock" treatment on the NGDS machine. Participant will complete experience questionnaires.

Study Details

The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering radiation in shorter treatment time and better patient tolerance, with less breath holding.

Key Dates

First listed
Sep 17, 2026
Start date
Jul 31, 2026
Status verified
Sep 2026
Primary completion
Feb 28, 2027
Completion
May 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Other: Single Arm - All patients will be treated the same
    "Mock" treatment on the NGDS machine.

Primary Outcome Measure

To evaluate the feasibility of the mock NGDS DMAT workflow under breath hold conditions. [ Time Frame: From enrollment to end of "mock" treatment of last participant enrolled, assessed up to 6 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Siteman Cancer Center Washington UniversitySt LouisMissouri63108
Pamela Samson (PRINCIPAL_INVESTIGATOR)
University Hospital Cleveland Medical CenterClevelandOhio44106
Carly Croyle, BS
216-844-7087
Lauren Henke (PRINCIPAL_INVESTIGATOR)

Find similar trials in St Louis, MO

By condition

Related Studies